Download presentation
Presentation is loading. Please wait.
Published byBerenice Oliver Modified over 8 years ago
2
Colon cancer: the second leading cause of cancer deaths in the U.S. Polyps, the first stage In tumor development http://www.clevelandclinic.org/registries/inherited/fap.htm
4
Familial adenomatous polyposis (FAP) = inherited predisposition to colon cancer
5
Cancer cells proliferate without differentiating, a property of our body’s normal stem cells
7
Normal cells are “contact-inhibited” and stop growing when they reach confluence Tumor cells are no longer “contact inhibited”
8
Cancer cells have alterations in cell adhesion and the cytoskeleton Normal “Transformed”
9
Normal Dysplasia Carcinoma in situ Malignant carcinoma Cancer develops through gradual changes in cell morphology and properties
10
Benign tumor Break through basal lamina Invade capillary Adhere to capillary wall Escape capillary Form metastasis Metastasis: the movement of tumor cells to new sites via the blood vessels or lymphatic system
12
Some normal cells like those of the neural crest have similar properties but end by differentiating at their new sites
13
The forces of Natural Selection drive the multistep process ECB Fig. 21-44
14
A single mutation is NOT enough!
15
Cancer cells accumulate chromosomal abnormalities
16
What types of genes are mutated in cancers? Two broad categories Oncogenes Mutational activation of proteins that normally Promote cell proliferation
17
What types of genes are mutated in cancers? Two broad categories Oncogenes Mutational activation of proteins that normally Promote cell proliferation Tumor suppressor genes Mutational inactivation of proteins that normally inhibit cell proliferation
18
Cells instruct one another via cell-cell signals
19
Signal transduction moves information from the cell surface to the nucleus & other cellular targets
20
Signal transduction occurs in a series of steps
21
Cell-cell signals can regulate cell proliferation
22
Cancer often results from alterations in proteins in signal transduction pathways
23
Cancer often results from alterations in proteins in signal transduction pathways
24
Src in its normal context Normal skin cell tightly adherent to ECM Wounding->platelet recruitment-> cell migration and proliferation
25
Many viral oncogenes are kinases including receptor tyrosine kinases
26
Activating mutations in RTKs take several forms but all lead to ligand-independent dimerization and thus activation
27
Double minute chromosomes Tandem duplications Gene amplification is also a common mechanism of inappropriate gene activation in human tumors
28
RTK signaling ultimately leads to activation of a transcription factor Gilbert Fig. 6.15
29
Elements of the ras signal transduction pathway are often activated in cancers
30
Remember this?
31
The vul mutations helped define the RTK-Ras pathway
32
We are making progress: The modern drug Gleevec stops certain cancers by blocking the kinase activity of protein tyrosine kinases Gleevec works for chronic myeloid leukemia
33
Lipid bilayer Outside the cell Inside the cell Steel White-spotting Tyrosine kinase domain In response to binding of Steel factor, kinase is activated and target proteins are phosphorylated P (aka c-kit) Gleevec also works for the cancers caused by activation of White-spotting=(c-kit)
34
What types of genes are mutated in cancers? Two broad categories Oncogenes Mutational activation of proteins that normally Promote cell proliferation Tumor suppressor genes Mutational inactivation of proteins that normally inhibit cell proliferation
35
E2F DP DO NOT transcribe gene required for DNA replication Rb Rb puts the brakes on cell proliferation
36
E2F DP Transcribe gene required for DNA replication P P Rb phosphorylation frees E2F/DP to turn on genes required for proliferation
37
Retinal tumor in patient that inherited a mutant copy of Rb
38
Even though its caused by a loss-of-function mutation Retinoblastoma is inherited in a dominant fashion What’s up with that?
41
Mechanisms to inactivate the second Rb allele
43
One strategy for isolating oncogenes
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.